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Edited by Hans EklundAbstract We have mapped the sites of ischemia/reperfusion-in-
duced phosphorylation of cytochrome c oxidase (CcO) subunits
in rabbit hearts by using a combination of Blue Native gel/Tri-
cine gel electrophoresis and nano-LC–MS/MS approaches. We
used precursor ion scanning combined with neutral loss scanning
and found that mature CcO subunit I was phosphorylated at tan-
dem Ser115/Ser116 positions, subunit IVi1 at Thr52 and subunit
Vb at Ser40. These sites are highly conserved in mammalian spe-
cies. Molecular modeling suggests that phosphorylation sites of
subunit I face the inter membrane space while those of subunits
IVi1 and Vb face the matrix side.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cytochrome c oxidase (CcO) is the terminal oxidase of the
mitochondrial electron transport chain, which catalyzes the
reduction of molecular O2 to water and uses the free energy
of the reaction to build the DWm. This important rate limiting
enzyme is subject to regulation by ATP:ADP ratios with ATP
acting as an allosteric inhibitor and ADP as allosteric activa-
tor. A number of studies also suggest that CcO activity may
be regulated by subunit phosphorylation. Miyazaki et al. [1]
showed a positive correlation between CcO activity and mito-
chondrial c-Src kinase in osteoblasts. In vitro studies with
mitochondrial membranes incubated with [c32P] ATP revealed
phosphorylation of subunit IVi1 by an endogenous kinase [2].Abbreviations: CcO, cytochrome c oxidase; BNGE, blue native gel
electrophoresis; PKA, protein kinase A; PKC, protein kinase C; ROS,
reactive O2 species; TFA, triﬂuoroacetic acid; nano-LC–MS/MS, na-
nobore liquid chromatography/electrospray ionization tandem mass
spectrometry
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doi:10.1016/j.febslet.2007.02.042Similarly, phosphorylation of CcO subunits I, II/III and Vb
in vitro in puriﬁed CcO enzyme was reported by Bender and
Kadenbach [3]. Recently, Lee et al. [4] showed that CcO sub-
unit I in bovine liver mitochondria was phosphorylated, which
was induced by cellular cAMP/PKA activity. Using a high res-
olution LC–MS method these authors also mapped the phos-
phorylation site in the bovine subunit I to Tyr 304 [4] and
showed that subunit phosphorylation was closely related to
changes in CcO activity and the aﬃnity of the enzyme for cyto-
chrome c binding.
In a recent study, we showed that murine macrophage cells in
culture exposed to hypoxia, and in vitro Langendorﬀ perfused
rabbit heart, subjected to ischemia, resulted in phosphorylation
of CcO subunits I, IVi1, and Vb [5]. Phosphorylated enzyme
from cells grown under hypoxic conditions, and rabbit hearts
subjected to global or focal ischemia showed markedly reduced
CcO activity and increased production of reactive O2 species
(ROS) in an in vitro reconstituted system. Protein kinase A
(PKA) inhibitor, H89 (50 nM) added to culture medium or to
Langendorﬀ perfusion medium attenuated hypoxia and ische-
mia induced inhibition of CcO activity and ROS production
[6]. In the present study, using a combination of Blue Native
Gel (BNG) electrophoresis, resolution of subunits by Tricine
gel electrophoresis and nanobore liquid chromatography/
electrospray ionization tandem mass spectrometry (nano-LC–
MS/MS) analysis of peptides generated by in-gel trypsin or
chymotrypsin digestion, we have mapped the possible ische-
mia-induced phosphorylation sites on subunits I, IVi1, and
Vb of CcO from rabbit hearts subjected to ischemia/reperfu-
sion. Our results suggest that ischemia mediated phosphoryla-
tion of each of the three subunits are most likely targeted to
single sites and are highly sensitive to a known PKA inhibitor,
H89.2. Materials and methods
2.1. Chemicals
Chemicals used were of highest analytical grade and obtained either
from Sigma Chemical Company, Fisher Scientiﬁc Co. or from Prome-
ga Inc. (Madison, Wisconsin).2.2. Ischemia and reperfusion in vitro in rabbit hearts
All animal procedures were carried out in conformance with the
guidelines for the Care and Use of Laboratory Animals from the Na-
tional Institutes of Health. Hearts from New Zealand male whiteblished by Elsevier B.V. All rights reserved.
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perfusion apparatus as described before [6]. Global ischemia was in-
duced by lowering the rate of perfusion to 2.5 ml/min as opposed to
the normal rate of 40 ml/min. We have used 30 min of global ischemia
in all the experiments reported here. In some experiments H89 (50 nM)
was included both in the preperfusion and perfusion medium. Age
matched sham perfused hearts (40 ml/min throughout) were used as
controls. Detailed protocols on the induction of global and focal ische-
mia and the evaluation of ischemic damage were described elsewhere
[5,6].2.3. Separation of native respiratory complexes from rabbit heart
mitochondria
The blue native gel electrophoresis (BNGE) protocol was similar to
that described before [7]. Mitochondrial membrane complexes were sol-
ubilized with 1% laurylmaltoside in the presence of 750 mM 6-aminoca-
proic acid and the phosphatase inhibitors (1 mM each of sodium
vanadate, sodium ﬂuoride, and 0.1 mM ammonium molybdate). Sam-
ples were cleared at 100000· g for 30 min andmixed with 5% Serva blue
dye. Thyroglobulin, apoferritin and b-amylase were used as size mark-
ers. First dimensional BNGE was performed on a native 6–13% poly-
acrylamide gradient gel starting with a current of 100 V and
increasing to a constant current of 250 V. Details of buﬀers and electro-
phoresis were as described before [7]. The CcO complex was identiﬁed
based on the size and reactivity to antibodies.2.4. Resolution of CcO subunits by Tricine–SDS gel electrophoresis in
the second dimension
Preparation of the gel and running conditions for the second dimen-
sion Tricine–SDS–PAGE were according to Schagger and von Jagow
[7]. The excised CcO bands from BNGE were soaked in 1% SDS
and 1% mercaptoethanol for 1 h. Gel pieces were layered on top of a
10% Tricine–SDS gel (3.5% cross-linked) and the electrophoresis was
performed at room temperature at 100 V. The gel was stained with
Coomassie blue, destained and individual bands were excised and used
for LC–MS/MS analysis.2.5. In-gel digestion of protein
The in-gel digestion of protein was adopted from UCSF (Mass Spec-
trometry facility, University of California, San Francisco; dona-
tello.ucsf.edu/ingel.html). CcO-IVi1 and Vb were digested overnight
at 37 C with trypsin (12.5 ng in 50 mM NH4HC03). CcO subunit I
was digested with chymotrypsin (12.5 ng in 50 mM NH4HCO3) at
37 C for 6 h. The peptides were extracted twice from gel slices with
50 ll of 0.1% triﬂuoroacetic acid (TFA) in 60% acetonitrile and dried
in a Speed-Vac. The dried peptides were dissolved in 0.1% TFA for fur-
ther analysis by nano-LC–MS/MS.2.6. Nanobore LC–MS/MS analysis
The nanobore LC system was performed on an Agilent LC 1100
(Agilent, Wilmington, DE) ﬁtted with an auto sampler (Model
G1377A) and a nano pump (Model G2225A). The system was inter-
faced with an ABI QSTARXL mass spectrometer (Applied Biosys-
tems/MDS Sciex, Framingham, MA).The spray capillary was a
PicoTip Silica Tip emitter with a 15 lm tip (New Objective, Woburn,
MA).
The nanobore LC separation column was a 75 lm ID · 150 mm
length reverse-phase C18 column (Grace-Vydac, Hesperia, CA) and
the pre-column was a 1 mm · 3 mm reverse-phase C18 column (Agi-
lent, Wilmington, DE). The pre-column was washed and equilibrated
with 0.1% formic acid and 0.02% TFA at a ﬂow rate of 15 ll/min
for a total of 4 min to remove salts. For each run 5 ll of sample was
injected to the pre-column and washed for 4 min to remove salts.
The nanobore separation column was eluted with a binary mobile-
phase gradient of 5–90% acetonitrile in H2O containing 0.1% formic
acid and 0.02% TFA at a ﬂow rate of 0.4 ll/min using the following
program:Time (min) 0 5 50 55 65 70 80
Eluent B (%) 5 5 50 70 70 5 5 StopFor nanospray, acquiring parameters were a curtain-gas setting of
15 and an ionspray voltage setting of 2500–2800 V. In the Q0 region,
the instrument parameters were set at declustering potential (DP) of
60 V and a focusing potential (FP) of 220 V. Nitrogen was used as
the collision gas at a setting of CAD = 5 for both TOF MS and MS/
MS scans. All nano LC–MS/MS data were acquired in Information-
Dependent Acquisition (IDA) mode in Analyst QS SP8 with Bioana-
lyst Extension 1.1 (Applied Biosystems/MDS Sciex). The mass
spectrometer was operated in the IDA mode, which involves switching
from MS to MS/MS mode on detection of singly, doubly and triply
charged species above a preset threshold.2.7. Data analysis
Data analysis for identiﬁcation of proteins and phosphorylation
sites were performed with SwissProt Data base using the Mascot
searchlog engine, and Protein Prospect programs [8]. The tolerance
set for peptide identiﬁcation was 0.3 Da for MS and 0.2 Da for MS/
MS. The search results for all three subunits are shown in Table 1.
The search for phosphorylation sites was carried out by setting the
Phos (ST) function to variable modiﬁcation and the MS/MS spectra
were manually inspected and checked for the neutral loss of 98 Da
(H3PO4) from phosphorylated fragment ion for correction.2.8. Sequence determination for rabbit CcO Vb subunit
Total RNA was isolated from rabbit heart using TRIZOL (Invitro-
gen, Carlsbad, CA), and a cDNA pool was created using the cDNA
Archive Kit (Applied Biosystems, Foster City, CA). Following cDNA
synthesis, the region corresponding to the CcO Vb phosphopeptide
was ampliﬁed using the forward primer 5 0-GGACTGGACCC ATA-
CAATATGCTAC-CTCC-30 (mouse sequence for peptide fragment 2
in Fig. 2C) and the reverse primer 5 0-ATGGGTTCCACAGT-TGG
GGCA-3 0 (mouse sequence for peptide 5 in Fig. 2C), and the nucleo-
tide sequence of the ampliﬁed DNA was determined.2.9. Three-dimensional modeling of CcO subunits
The three-dimensional structural models for wildtype and phosphor-
ylation mutants of rabbit cytochrome oxidase subunits I, IVi1 and Vb
were developed using the Swiss-Model software [9]. The models were
built based on the X-ray structure coordinates published by Tsukihara
et al. [10] and listed in the PDB data bank. The accuracy of the model
was veriﬁed by energy calculations using Gramos 96 software. 3D visu-
alization and renderings were achieved by the Swiss PDB viewer.3. Results
3.1. Phosphorylation state of CcO subunits under ischemia
Fig. 1A shows the blue native gel patterns of laurylmaltoside
solubilized mitochondrial complexes from control rabbit heart,
hearts subjected to 30 min of global ischemia followed by 2 h
reperfusion, and hearts perfused with H89-containing buﬀer
before being subjected to ischemia/reperfusion injury. Results
show resolution of complex I, F1/Fo ATPase (complex V),
cytochrome b–c1 complex (complex III), CcO (complex IV)
and succinate dehydrogenase complex (complex II). The iden-
tiﬁcation of diﬀerent complexes was based on cross-reactivity
to antibodies against complex-speciﬁc subunits and also the
BNG patterns as reported previously by Schagger and von
Jagow [7]. Gel slices of CcO complex were loaded on a 10%
Tricine gel and individual subunits were resolved in the second
dimension. Fig. 1B shows the resolution of eight bands, many
of which contain multiple subunits. Individual subunits were
identiﬁed based on a combination of immunoblot analysis with
antibodies to human CcO subunits and LC–MS/MS analysis
of in gel tryptic digests of diﬀerent bands. We have identiﬁed
all the 13 subunits using this approach. As reported before, rel-
ative levels of subunit I, IVi1 and Vb were signiﬁcantly reduced
Table 1
Quantitation of CcO subunit peptides from control and ischemic rabbit hearts analyzed by LC–MS/MS
Species Subunit Sample Sequence coverage (%) Matched peptides Score Digested with
Rabbit I Control 32 17 258 Chymotrypsin
I Ischemia 29.5 14 243 Chymotrypsin
I H89 30 15 215 Chymotrypsin
Rabbit IVi1 Control 62 10 538 Trypsin
IVi1 Ischemia 65.3 11 495 Trypsin
IVi1 H89 61.2 13 397 Trypsin
Rabbit Vb Control 65.3 7 212 Trypsin
Vb Ischemia 66.3 7 281 Trypsin
Vb H89 63.3 7 220 Trypsin
1304 J.-K. Fang et al. / FEBS Letters 581 (2007) 1302–1310in the complex from the ischemic heart, and the subunit levels
were nearly completely restored in complexes where H89 was
added to the perfusion medium throughout the procedure.
3.2. Identiﬁcation of subunits by LC–MS/ MS
Identiﬁcation of subunits I, IVi1 and Vb from control and
ischemic rabbit heart were performed by LC–MS/MS. Table
1 summarizes the results of the data base search involving frag-
ments of 450–3000 Da masses. Since subunit I contains a lim-
ited number of basic residues, trypsin digestion did not
produce a suﬃcient number of peptide fragments for mass
analysis. Thus, we chose to digest subunit I with chymotrypsin,
which produced large number of peptides in the mass range
that were amenable for mass analysis. However, this treatment
also yielded a large number of fragments below the detection
limit (less than 450 Da) resulting in a relatively low recovery
of 30–32% (Table 1). In the case of subunits IVi1 and Vb,
on the other hand, trypsin digestion yielded a higher recovery
of 60–66% (see Table 1).
The SwissProt data base did not contain rabbit subunit Vb
sequence. However, several of the rabbit Vb peptides matched
with the bovine and mouse homologs with respect to their























Fig. 1. Two-dimensional resolution of CcO complex from rabbit heart mitoc
subjected to global ischemia/reperfusion with or without added H89 was s
BNGE (A) as described in Section 2. Complex IV was excised and resolved
stained BNGE (A) and Tricine gels (B) have been presented. The subunit idVb sequence by cDNA ampliﬁcation and nucleotide sequenc-
ing as described below. The overall score in all three cases ran-
ged from 212 to 538 indicating high conﬁdence matches.
Subunit Vb from diﬀerent mammalian sources showed <90%
amino acid sequence identity. The peptides analyzed by MS/
MS show very high conﬁdence, and most of the y and b ions
resolved on the mass spectra exhibited values identical to the-
oretical values.
The peptides identiﬁed for mature subunits I, IVi1 and Vb
are shown in Fig. 2A–C, respectively. Fig. 2A and B shows
rabbit CcO I and IVi1 sequences and Fig. 2C shows the mouse
CcO Vb sequence. The region of rabbit sequence we generated
by partial cDNA sequencing is indicated in Fig. 2C. For this
purpose, we used sense and anti-sense primers corresponding
to peptide 1 and peptide 5, respectively, of the mouse sequence
shown in Fig. 2C. There was only one A/T variation in the rab-
bit sequence as shown in Fig. 2C (shown in parenthesis).
3.3. Identiﬁcation of phosphorylated sites in CcO subunit I, IVi1
and Vb
By comparing the MS chromatograms for subunits from
control and ischemia induced hearts we attempted to ﬁnd the























hondria: 200 lg of mitochondria from control rabbit hearts and hearts
olubilized in 1% laurylmaltoside and the complexes were resolved by
on Tricine–SDS gels in the second dimension (B). Coommassie blue









= Peptides identified by nano LC-MS/MS analysis
= Phosphorylated sites (S115,S116)
115/116





= Phosphorylated site (T52 )
52
=peptides identified by nano LC-MS/MS analysis
=phosphorylated site (S40)
[a]. No.2,3,4 and 5 peptides are identical to bovine peptides by mass
[b]. No.1,2,4 and 5 peptides are identical to mouse peptides by mass
C
gldpynmlppkaasgtkedpnlvpsitnkrivgciceednstviwfqlhkgetqrcpncgth yklvphqlah
1[b] 2[a,b] 3[a] 4[a,b] 5[a,b]
40 (A)
Fig. 2. Sequence regions of CcO subunits I, IVi1 and Vb covered by the nano-LC–MS/MS analysis. A. chymotryptic digests of subunit I, and tryptic
digests of subunits IVi1 (B) and Vb (C). Fragments identiﬁed by nano-LC–MS/MS analysis have been underlined. The rabbit sequences for subunit I
(A), and IVi1 (B) and mouse sequence for Vb (C) are presented. The boxed area in C represents the rabbit Vb sequence characterized in this study by
RT-PCR and nucleotide sequencing. A single amino acid variant between the mouse and rabbit within this stretch (A/T) is indicated in parenthesis.
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bullet), found in IVi1 from ischemic heart, was not detected in
the subunit from control hearts and also hearts perfused with
PKA inhibitor, H89 (Fig. 3A). The ion 484.7530 (double
charge) found only in subunit IVi1 from ischemic hearts
yielded a sequence pattern of APWGSLpTR on MS/MS anal-
ysis (Fig. 3B). The corresponding precursor ion 444.2894 (dou-
ble charge) from control, H89 treated, and also ischemic hearts
yielded sequence APWGSLTR. The theoretical mass of this
peptide by Mascot based data analysis is 444.24. These results
clearly show that rabbit CcO subunit IVi1 is phosphorylated at
T52. We did not ﬁnd any other putative phosphopeptide in the
sequence region covered by this analysis (shown in Fig. 2B).
The same strategy was used to identify phosphopeptides
from CcO subunits I and Vb. As shown in Fig. 3C, MS/MS
analysis of ion 654.38 (double charge) unique to hearts sub-
jected to ischemia/reperfusion revealed a peptide sequence ofLAGVpSpSILGAINF with tandem Ser residues at position
115 and 116 of mature subunit I carrying phosphoryl residues.
Fig. 3D shows that MS/MS analysis of ion 702.31 (single
charge), unique to subunit Vb from hearts subjected to ische-
mia/reperfusion yielded a phosphopeptide sequence of ATp-
SESK with the phosphorylation site mapping to S40 of the
mature rabbit subunit.
A sequence comparison (Fig. 4) shows that the putative
phosphorylation sites of T/S52 of subunit IVi1, T/S40 of sub-
unit Vb and S115/S116 of subunit I are highly conserved
among the mammalian species.
3.4. Spatial orientation of phosphorylated domains of CcO
subunits
A computer based homology modeling based on the known
X-ray crystal structure of bovine CcO [9,10] was carried out to
understand the spatial orientation of phosphorylated sequence
Fig. 3. Identiﬁcation of ischemia-induced phosphorylation sites of rabbit CcO subunits I, IVi1 and Vb. Figure A shows the nano-LC–MS/MS
patterns of subunit IVi1 from ischemic (upper panel), control (middle panel) and hearts subjected to ischemia in the presence of added H89. Note that
only the subunit from ischemic heart shows the presence of the double charged 484.7541 ion (marked with d). The parent double charged ion
444.2404 diﬀering by 80 Da is seen in all three samples (marked with .). In Figure B, MS/MS analysis of double charged ion 444.2404 showed an
amino acid sequence of APWGSLPTR, while that of double charged ion 484.7541 yielded sequence of APWGSLpTR. Figure C represents the MS/
MS analysis of double charged ion 654.38 from subunit I from ischemic heart, which showed an amino acid sequence of LAGVpSpSILGAINF, and
in Figure D, MS/MS analysis of single change ion 702.31 from CcO subunit Vb from ischemic hearts is presented. The pattern shows amino acid
sequence of ATpSESK.
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ylated S115/S116 of CcO I in the fully assembled complex are
part of the loop out regions fully exposed to the aqueous exte-
rior facing the intermembrane space. The putative phosphory-
lation sites of subunit IVi1 and Vb (Fig. 5B) are also part of
surface exposed regions of the proteins, but they face the ma-
trix side. Although not shown, the phosphorylation sites of all
three subunits are fully exposed even in the context of the
structure with all 13 subunits in place. These results suggest
that the CcO complex is phosphorylated on both the matrix
and intermembrane facing sides during myocardial ischemia/
reperfusion.4. Discussion
CcO is regulated by hormones/second messengers, mem-
brane lipid environment and also by protein modiﬁcation[4,5,11–13]. It is long known that thyroid hormone induces res-
piration-coupled thermogenesis and recent biochemical and
structural studies indicate that T2 modulates the CcO activity
by binding to subunit Va [14,18]. Oxidation of cardiolipin in
the inner mitochondrial membrane during various oxidative
stress conditions is another important factor that aﬀects CcO
function [15,18]. There is also increasing evidence that endog-
enously produced NO and lipid peroxides modulate O2 con-
sumption by inhibiting CcO activity [16,17]. cAMP mediated
phosphorylation of CcO subunits has recently emerged as a
major mechanism for regulation of CcO function under vari-
ous stress conditions [18]. In vitro studies with isolated CcO
enzyme or mitochondrial membrane fraction [3] suggested that
PKA mediated phosphorylation aﬀects CcO activity possibly
by altering the aﬃnity for binding to its allosteric activator,
ADP. These conclusions were conﬁrmed and extended by a re-

















Fig. 5. Membrane topology of phosphorylation sites of subunits I, IVi1 and Vb in their 3D arrangement. Three-dimensional models for rabbit CCO
subunits I (A) and IVi1 and Vb (B) were developed based on the sequence homology to bovine cytochrome oxidase subunits and X-ray structure
coordinates of bovine CcO [10] listed in PDB database. The Swiss-Model software was used for developing the model as described in Materials and
Methods. The accuracy of the models were veriﬁed by energy calculations using Gramos 96 software.
CcO subunit I                    115/116
Rabbit:    PLAGNLAHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMSQYQ
Mouse:    PLAGNPVHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMTQYQ
Human:   PLAGNYSHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMTQYQ
Rat:         PLAGNLAHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMTQYQ
Bovine:    PLAGNLAHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMSQYQ
Pig:          PLAGNLAHAG  ASVDLTIFSL  HLAGVSSILG  AINFITTIIN  MKAPAMSQYQ
CcO subunit IVil 52
Rabbit:    HVKQLSAGQK  ALKEKEKAPW  GSLTRDEKVE  LYRIQFNESF  AEMNRGTNEW
Mouse:    HVTMLSAS QK  ALKEKEKADW SSLSRDEKVQ   LYRIQFNESF  AEMNRGTNEW
Human:   HVKHLSAGQK  ALKEKEKASW SSLSMDEKVE  LYRIKFKESF  AEMNRGSNEW
Rat:          HVKLLSAGQK  ALKEKEKADW  SSLSRDEKVQ   LYRIQFNESF  AEMNKGTNEW
Bovine:     HVKNLSASQK ALKEKEKASW  SSLS I DEKVE  LYRLKFKESF  AEMNRSTNEW
Pig:           HVKNLSASQK   AXKEKEKASW  SSLSMDEKVE  LYRLKFLESF  AEMNRSTNEW
CcO subunit Vb 40
Rabbit:     GLDPYNMLPPK ATSESKEDPNLVP  SITNK
Mouse:     GLDPYNMLPPK AASGTKEDPNLVP  SI SNK
Human:    GLDPYNVLAPK  GASGTREDPNLVP  SI SNK
Rat:          GLDPYNMLPPK  AASGTKEDPNLVP  SVSNK
Bovine:    GQDPYNI LAPK ATSGTKEDPNLVP  SI SNK
Pig            GLDPYNI LAPK   AASGTKEDPNLVP  SITNK
Fig. 4. Conserved nature of phosphorylation sites of CcO subunits I, IVi1 and Vb. Comparison of amino acid sequence of rabbit subunits with the
mouse, human, rat, bovine and pig shows that phosphorylation sites S115/S116 of subunit I, T/S52 of subunit IVi1 and S40 of subunit Vb are highly
conserved among the mammalian species.
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hypoxic conditions and rabbit hearts subjected to ischemia/
reperfusion by Langendorﬀ perfusion, the altered CcO activity
is directly linked to subunit phosphorylation. Inhibition of
CcO activity under these conditions could be reversed by the
PKA inhibitor H89 [5]. Our results also showed that subunits
I, IVi1 and Vb are the major targets of protein phosphoryla-
tion under these pathophysiological conditions. In extensionof this study, we have now mapped phosphorylation sites of
these three subunits using a nano-LC–MS/MS method. Our re-
sults show that two tandem Ser residues (Ser115/Ser116) of
subunit I, Thr/Ser52 of subunit IVi1 and Ser40 of subunit
Vb are phosphorylated. In all three cases, the phosphopeptides
were nearly undetectable in control CcO samples as well as
those pretreated with PKA inhibitor H89 suggesting that the
phosphorylation sites map to single peptide regions. The phos-
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to known phosphorylation sites, while the phosphopeptide
from Vb shows partial (50%) consensus to both PKA and
CKII. Thus the precise nature of the kinase(s) involved in
the ischemia-induced phosphorylation remains unclear, except
that they are inhibited by 50 nM H89.
Recently, Lee et al. [4] showed that subunit I of bovine li-
ver is phosphorylated at Tyr 304. We did not detect this
phosphopeptide in our analysis since the approach used here
is not sensitive enough to detect phosphor-Tyr residues. It is
also possible that our inability to detect phosphorylation of
Tyr 304 in rabbit heart subunit I represents a tissue speciﬁc
diﬀerence. However, our results for the ﬁrst time conﬁrm
that indeed three of the CcO subunits are phosphorylated
in a site speciﬁc manner during hypoxia and ischemia and
that the phosphorylation in all three cases is inhibited by
H89.
Molecular modeling based on X-ray crystal structure [9,10]
suggests that the phosphorylated Ser115/Ser116 of Cox I sub-
unit residues are part of a loop out structure facing the inter-
membrane space that is fully exposed to the aqueous exterior.
A similar intermembrane space orientation has been sug-
gested for Tyr 304 phosphorylation [4]. The phosphorylated
domains of subunits IVi1 and Vb, on the other hand, face
the matrix side, fully exposed to the aqueous environment.
Although the precise nature of the kinase(s) involved in the
phosphorylation remain unclear, it is known that the mito-
chondrial compartment from diﬀerent cells/tissues show vari-
ous kinase activities under diﬀerent physiological conditions
[19,20]. Our own results show that both hypoxia and ische-
mia/reperfusion induce mitochondrial PKA activity [5]. Some
studies suggest that PKCe physically interacts with CcO sub-
unit IVi1 and phosphorylates it [21,22], while other studies
show that PKCd tranlocation to mitochondria contributes
to ischemia- induced mitochondrial damage [23]. Although
protein kinase C (PKC) inhibitor Go6850 failed to inhibit hy-
poxia- and ischemia/reperfusion-induced phosphorylation of
all three subunits [5], we can not rule out the possibility that
some yet uncharacterized PKC isoform or other type of
protein kinases are responsible for the observed phosphoryla-
tion.
A number of in vitro and in vivo studies have provided com-
pelling evidence on the direct role of protein phosphorylation
on CcO function [1,2,4,18]. Additionally, studies reported
from our laboratory also suggests that phosphorylated CcO
may directly or indirectly contribute to increased ROS produc-
tion and hence cell/tissue injury [5]. For these reasons a conclu-
sive evidence on subunit phosphorylation during hypoxia/
ischemia and mapping of phosphorylation sites described in
this study have important signiﬁcance in understanding hypox-
ia/ischemia mediated changes in CcO structure and function
and pathophysiological consequence of these changes.
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